|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Regions :: Western Europe :: Switzerland
Displaying 201 - 220 of 389 stories.
November 4, 2010
Dottikon (Dottikon, Switzerland), a pharmaceutical fine chemical company, says it expects to post a net loss for the fiscal year ending March 31, 2011, and that corresponding sales...http://www.chemweek.com/regions/western_europe/switzerland/Currency-Pressure-Project-Delays-Push-Dottikon-to-Net-Loss_30714.html November 3, 2010
Clariant's third-quarter sales and profits rose compared to the year-ago period because of solid demand, higher selling prices, and cost reduction programs that were already in place...http://www.chemweek.com/regions/western_europe/switzerland/Clariants-Quarterly-Results-Rise-on-Improved-Demand-and-Higher-Selling-Prices_30689.html October 27, 2010
Lonza, in its business update announcement for the third quarter of 2010, says that its sales figures for the quarter are strong. The newly signed contracts and pipeline deals in the...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Improved-Business-Development-in-Custom-Manufacturing_30473.html October 15, 2010
Sika (Baar, Switzerland) says its Sika Corp. (Lyndhurst, NJ) subsidiary has acquired May National Associates (Lakewood, NJ), a manufacturer of silicone and polyurethane products for...http://www.chemweek.com/regions/western_europe/switzerland/Sika-Acquires-U-S-Firm_30262.html October 15, 2010
Clariant has announced the third and final step in its previously discussed Global Asset Network Optimization (Gano) project. Gano was initiated in November 2009, following the...http://www.chemweek.com/regions/western_europe/switzerland/Clariant-Consolidates-Sites-as-Part-of-Major-Restructuring_30264.html September 29, 2010
Nycomed (Zurich, Switzerland) says its Zydus Nycomed (Navi Mumbai, India) joint venture with Zydus Cadila (Ahmedabad, India) has commissioned its expanded active pharmaceutical...http://www.chemweek.com/regions/western_europe/switzerland/Nycomed-JV-Opens-API-Facility-in-India_29850.html September 23, 2010
Lonza says it has entered into a preferred marketing and sales agreement with biotechnology company Scarab Genomics (Madison, WI) for Scarab Genomics’ Clean Genome E. coli...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Signs-Deal-with-Scarab-Genomics_29704.html September 7, 2010
Lonza says it has entered into an agreement with GlaxoSmithKline (GSK; London) under which Lonza will support the ongoing development of GSK’s biopharmaceutical pipeline by...http://www.chemweek.com/regions/western_europe/switzerland/GSK-and-Lonza-Sign-Manufacturing-Deal_29301.html September 6, 2010
Ems-Chemie (Domat/Ems, Switzerland) says that two of its former employees, former head of accounts and a former salesman, have received prison sentences for fraud, falsification of...http://www.chemweek.com/regions/western_europe/switzerland/Two-Former-Ems-Chemie-Employees-Receive-Prison-Sentences_29272.html September 1, 2010
Givaudan says it will invest SF170 million ($165.4 million) to build a savory flavors production facility at Mako, Hungary in order to supply the “fast growing” markets of...http://www.chemweek.com/regions/western_europe/switzerland/Givaudan-Plans-Flavors-Plant-In-Hungary-Closes-U-K-Site_29136.html August 31, 2010
Siegfried (Zofingen, Switzerland) reported a net loss of SF2.3 million ($2.25 million) in the first six months of 2010, compared with a net profit of SF0.6 million in the year-ago...http://www.chemweek.com/regions/western_europe/switzerland/Siegfried-Reports-a-Loss-in-First-Half_29107.html August 30, 2010
Lonza says it has entered the viral-based manufacturing market with its acquisition of Vivante GMP Solutions (Houston, TX). Vivante is a custom manufacturing organization producing...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Acquires-U-S-Contract-Manufacturer_29104.html August 5, 2010
Givaudan's first-half sales and profits rose on improved demand compared to the year-ago period. Net income soared 108%, to SF200 million ($191 million), on sales up 11%, to...http://www.chemweek.com/regions/western_europe/switzerland/Givaudans-Earnings-Jump-on-Higher-Demand_28567.html August 5, 2010
Lonza says it has entered into a research collaboration agreement with Roslin Cells (Roslin, U.K.) for the development of customized cell culture media and processes for the production...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Forms-Research-Collaboration-with-Roslin-Cells_28561.html August 4, 2010
Ineos Group Holdings (Lausanne) reported historical cost Ebitda (HC Ebitda) for the second quarter of 2010 of €478 million ($616.5 million), compared to €352 million in the...http://www.chemweek.com/regions/western_europe/switzerland/Ineos-Reports-Higher-Second-Quarter-Ebitda-on-Strong-Demand_28331.html July 29, 2010
The improved financial result reflects restructuring and a stronger economy....http://www.chemweek.com/regions/western_europe/switzerland/Clariant-Swings-to-a-Profit-in-the-Second-Quarter-Confirms-More-Plant-Closures_28415.html July 26, 2010
Lonza says that Daiichi Sankyo (Tokyo) has signed a research and commercial agreement with biotech company BioWa (Princeton, NJ), a subsidiary of Kyowa Hakko Kirin (Tokyo), and Lonza...http://www.chemweek.com/regions/western_europe/switzerland/Daiichi-Sankyo-Signs-Research-and-Commercial-Agreement-with-BioWa-and-Lonza_28321.html July 22, 2010
Lonza has recorded a 14.4% rise in first-half profits, to SF135 million ($130 million), compared to the year-ago period, and Ebitda increased by 3%, to SF309 million. Sales however...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Reports-Rise-in-First-Half-Profits_28221.html July 15, 2010
Lonza says it has signed an agreement with biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ), for the scale-up and commercial production of therapeutic monoclonal antibody...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-Extends-Manufacturing-Deal-with-Elusys_28062.html July 12, 2010
Lonza says it has entered into an agreement with Human Genome Sciences (HGS; Rockville, MD) for the future commercial supply of Benlysta (belimumab), which is currently under...http://www.chemweek.com/regions/western_europe/switzerland/Lonza-and-Human-Genome-Sciences-Sign-Manufacturing-Agreement_28010.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
